Publication Name	World Journal of Clinical Oncology
Manuscript ID	66915
Country	India

Received	2021-04-09 08:14
Peer-Review Started	2021-04-09 08:16
To Make the First Decision
Return for Revision	2021-06-28 08:50
Revised	2021-07-02 12:42
Second Decision	2022-07-22 07:47
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-07-25 03:10
Articles in Press	2022-07-25 03:10
Publication Fee Transferred
Edit the Manuscript by Language Editor	2022-07-19 03:27
Typeset the Manuscript	2022-08-17 09:35
Publish the Manuscript Online	2022-08-23 09:54

ISSN	2218-4333 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Cell Biology
Manuscript Type	Letter to the Editor
Article Title	COVID-19 and oral cancer: Critical viewpoint
Manuscript Source	Invited Manuscript
All Author List	Dharmarajan Gopalakrishnan, Sachin C Sarode, Gargi S Sarode and Namrata Sengupta
Funding Agency and Grant Number
Corresponding Author	Dharmarajan Gopalakrishnan, MDS, PhD, Dean, Professor, Department of Periodontology, Dr. D.Y. Patil Dental College and Hospital, Dr. D.Y. Patil Vidyapeeth, Sant Tukaram Nagar, Pimpri, Pune 411018, Maharashtra, India. drgopal@dpu.edu.in
Key Words	COVID-19; SARS-CoV-2; Oral cancer; Head and neck carcinomas; Oral squamous cell carcinoma
Core Tip	The outbreak of coronavirus disease 2019 (COVID-19) has evoked concern worldwide. The rapid spread of the disease during the first and the second waves caused severe respiratory illness. Individuals are facing a suppressed immune response. An impaired immune response has made patients with head and neck cancer highly susceptible to the viral infection. The two potential receptors of severe acute respiratory syndrome coronavirus 2, angiotensin receptors and extracellular matrix metalloproteinase inducer, have contrasting effects on cancer progression. Thus, the molecular mechanisms and the biological behavior of oral squamous cell carcinoma show varying effects in the background of COVID-19.
Publish Date	2022-08-23 09:54
Citation	Gopalakrishnan D, Sarode SC, Sarode GS, Sengupta N. COVID-19 and oral cancer: Critical viewpoint. World J Clin Oncol 2022; 13(8): 725-728
URL	https://www.wjgnet.com/2218-4333/full/v13/i8/725.htm
DOI	https://dx.doi.org/10.5306/wjco.v13.i8.725

Full Article (PDF)	WJCO-13-725.pdf
Full Article (Word)	WJCO-13-725.docx
Manuscript File	66915_Auto_Edited-ZMG-Filipodia-LS.docx
Answering Reviewers	66915-Answering reviewers.pdf
Audio Core Tip	66915-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	66915-Conflict-of-interest statement.pdf
Copyright License Agreement	66915-Copyright license agreement.pdf
Peer-review Report	66915-Peer-review(s).pdf
Scientific Misconduct Check	66915-CrossCheck.png
Scientific Misconduct Check	66915-Bing-Gong ZM-2.png
Scientific Editor Work List	66915-Scientific editor work list.pdf